Since our last feature on data exports in October 2020, we've seen significant developments including the EU's new draft standard contractual clauses, draft UK adequacy agreements and guidance on applying the Schrems II judgment. We also look at the impact of data export rules on clinical trial data, data exports from Asia, and data transfers in the context of M&A deals.
The new draft Standard Contractual Clauses – legal certainty for data transfers?
Paul Voigt looks at the pros and cons of the new draft SCCs.
Read more
Data transfers – will Asia lead the way?
Vin Bange and Jo Joyce look at the development of data transfer laws in Asia, focusing on six major jurisdictions.
Read more
Dealing with cross-border transfers and other data protection issues in M&A deals
Tamara Mackay-Temesy looks at data transfers and other issues in the context of M&A deals.
Read more
Path paved for EU-UK adequacy decisions
Debbie Heywood looks at the draft UK adequacy decisions published by the EC and what they mean for future EU-UK data exports.
Read more
EDPB guidance on data transfers to third countries in wake of Schrems II
Debbie Heywood looks at the EDPB recommendations on supplementing data transfer tools to help protect personal data exported to third countries.
Read more
How to keep clinical trial data flowing under GDPR and after Brexit
Debbie Heywood looks at cross-border transfers of clinical trial data in the UK and the EU.
Read more
